FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to developing an antirabic inactivated emulsion culture vaccine for prophylactic immunization of domestic carnivores and farm animals. Vaccine contains avirulent and purified antigenic material from strain "VNIIZZh" of rabies virus, obtained in transplantable suspension cell line from newborn golden hamster kidney (BHK-21/SUSP/ARRIAH), which is a suspension, containing predominantly immunogenic components of a rabies virus (glycoprotein and nucleoprotein), an oil adjuvant Montanide ISA-61 VG, a preservative merthiolate in effective ratios.
EFFECT: vaccine has high immunogenicity and is capable of providing long-term and reliable protection against rabies virus of the genetic line RABV.
10 cl, 16 dwg, 12 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
SERUM-FREE ENVIRONMENT “VNIIZZH” FOR THE CULTIVATION OF VNK-21 KIDNEY CELLS OF THE SYRIAN HAMSTER AND THE PRODUCTION OF IMMUNOGENIC COMPONENTS OF CULTURE-BASED VIRUSES OF FOOT-AND-MOUTH DISEASE AND RABIES FOR THE MANUFACTURE OF VACCINES | 2021 |
|
RU2770814C1 |
ASSOCIATED VACCINE AGAINST DISTEMPER, PARVOVIRUS AND CORONAVIRUS ENTERITIS, ADENOVIRUS INFECTION AND CANINE RABIES | 2023 |
|
RU2817255C1 |
CULTURAL INACTIVATED EMULSION VACCINE AGAINST FOOT AND MOUTH DISEASE FROM O NO. 2620/ORENBURGSKY/2021 STRAIN OF O/ME-SA/IND-2001E GENOTYPE | 2023 |
|
RU2815537C1 |
CULTURAL INACTIVATED EMULSION VACCINE AGAINST FOOT-AND-MOUTH DISEASE SEROTYPE O FROM STRAIN "O/ARRIAH/MYA-98" | 2023 |
|
RU2816944C1 |
CULTURAL INACTIVATED EMULSION VACCINE AGAINST O/EA-3 GENOTYPE FOOT-AND-MOUTH DISEASE OF O N2241/ETHIOPIA/2011 STRAIN | 2023 |
|
RU2816264C1 |
CULTURE INACTIVATED EMULSION VACCINE AGAINST FOOT-AND-MOUTH DISEASE OF SAT-2/XIV GENOTYPE FROM SAT-2/XIV/2023 STRAIN | 2024 |
|
RU2824660C1 |
VACCINE FOR EARLY PROTECTION AGAINST FOOT-AND-MOUTH DISEASE OF TYPE O INACTIVATED EMULSION | 2019 |
|
RU2699671C1 |
CULTURE INACTIVATED EMULSION VACCINE AGAINST FOOT-AND-MOUTH DISEASE OF ASIA-1/G-V GENOTYPE FROM ASIA-1/G-V/2006 STRAIN | 2024 |
|
RU2824662C1 |
METHOD FOR DETERMINING THE OPTIMAL TIME OF REPRODUCTION OF THE RABIES VIRUS IN THE CELLS OF THE KIDNEY LINE OF A NEWBORN SYRIAN HAMSTER BHK-21/SUSP/ARRIAH FOR THE MANUFACTURE OF ANTI-RABIES VACCINES USING THE ANALYSIS OF TRANSFORMATIONAL CHANGES IN CELLULAR DNA BY FLOW CYTOMETRY | 2022 |
|
RU2796497C1 |
CULTURE INACTIVATED EMULSION VACCINE AGAINST FMD OF O/SEA/MYA-98 GENOTYPE FROM O N2383/PRIMORSKY/2019 STRAIN | 2023 |
|
RU2804803C1 |
Authors
Dates
2020-06-04—Published
2019-11-05—Filed